Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) Tax Provisions (2016 - 2025)

Conmed's Tax Provisions history spans 16 years, with the latest figure at $12.5 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 26.57% year-over-year to $12.5 million; the TTM value through Dec 2025 reached $24.1 million, down 21.38%, while the annual FY2025 figure was $24.1 million, 21.38% down from the prior year.
  • Tax Provisions reached $12.5 million in Q4 2025 per CNMD's latest filing, up from $1.4 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $74.8 million in Q2 2022 to a low of -$37.1 million in Q4 2022.
  • Average Tax Provisions over 5 years is $4.6 million, with a median of $4.1 million recorded in 2023.
  • The largest YoY upside for Tax Provisions was 2396.16% in 2022 against a maximum downside of 1321.92% in 2022.
  • A 5-year view of Tax Provisions shows it stood at $5.2 million in 2021, then tumbled by 813.34% to -$37.1 million in 2022, then soared by 120.51% to $7.6 million in 2023, then increased by 29.89% to $9.9 million in 2024, then grew by 26.57% to $12.5 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Tax Provisions are $12.5 million (Q4 2025), $1.4 million (Q3 2025), and $8.5 million (Q2 2025).